Elevated CSN6 may be prognostic for poor survival colorectal cancer
the ONA take:
A study from The University of Texas MD Anderson Cancer Center identified a protein, CSN6, a subunit of a protein complex known as COP9 signalsome, that correlated with poor survival in patients with colorectal cancer. The researchers found that elevated CSN6 is a biomarker for worse recurrence-free survival in patients with colon cancer.
CSN6 is normally regulated through the EGFR and ERK signaling pathways. When overexpressed via ERK2 in particular, it leads to deregulation of beta-catenin, a transcription factor known to be linked to cancer development.
The current standard of treatment for colorectal cancer in patients at high risk of recurrent or metastatic disease includes surgery, chemotherapy, and targeted therapies.
The researchers report that defining the molecular alterations can help guide treatment and improve clinical care.
CSN6, a subunit of a protein complex known as COP9 signalsome, correlated with poor survival in patients with colorectal cancer.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Patient Navigation Reduces Delays in Diagnostic Resolution
- Fee-for-service Medicare Plans Linked to Improved Care During Last Year of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|